Molecular testing in oncology: Problems, pitfalls and progress-Reference-Cited by-同舟云学术

Molecular testing in oncology: Problems, pitfalls and progress

Published:2014-03 Issue:3 Volume:83 Page:309-315
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

O’Brien Cathal P.,Taylor Sarah E.,O’Leary John J.,Finn Stephen P.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference62 articles.

1. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer;Scagliotti;J Clin Oncol,2008

2. Randomized phase III study of trastuzumab, paclitaxel, and carboplatin compared with trastuzumab and paclitaxel in women with HER-2-overexpressing metastatic breast cancer;Robert;J Clin Oncol,2006

3. Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia;Cohen;Clin Cancer Res,2002

4. Imatinib and gastrointestinal stromal tumors: where do we go from here?;De Giorgi;Mol Cancer Ther,2005

5. Effects of preanalytical variables on the detection of proteins by immunohistochemistry in formalin-fixed, paraffin-embedded tissue;Engel;Arch Pathol Lab Med,2011

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world treatment patterns and survival of patients with ROS1 rearranged stage IV non-squamous NSCLC in the Netherlands;Lung Cancer;2023-07

2. A population-based study describing characteristics, survival and the effect of TKI treatment on patients with EGFR mutated stage IV NSCLC in the Netherlands;European Journal of Cancer;2022-04

3. Evaluation of NTRK immunohistochemistry as a screening method for NTRK gene fusion detection in non-small cell lung cancer;Lung Cancer;2021-01

4. Managing Deviating EQA Results: A Survey to Assess the Corrective and Preventive Actions of Medical Laboratories Testing for Oncological Biomarkers;Diagnostics;2020-10-18

5. Molecular Diagnostics for Lung Cancer;Molecular Diagnostics in Cancer Patients;2019